Autopsy report · NCT04200651

Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery

“COVID-19 challenges to recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 3 years 6 months before it stopped.
• 25 participants enrolled.
• Results were posted on the registry 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

The New York Eye Surgery Center

Sponsor type

University, hospital or other

Conditions

Glaucoma; Cataract

Interventions

Dexamethasone Ophthalmic Insert; Prednisolone Acetate 1% Oph Susp

Participants

25

Sites

1

Countries

United States

Trials that died the same way

• Compression Wraps as Adjuvant Therapy in Management of Acute Systolic Heart Failure
  “challenges in recruitment due to covid-19” (98% match in meaning)
• Acute Effects of the Prostaglandin (Alprostadil) on Cerebral and Pulmonary Flow
  “Covid 19 and difficulty with recruitment” (95% match in meaning)
• Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion
  “COVID 19 related recruitment problems” (92% match in meaning)
• Pathology and Imaging in Kidney Allografts
  “recruitment difficulties due to impact of COVID-19 pandemic” (91% match in meaning)
• A Feasibility Study of a Transdiagnostic Compassion Focused Therapy (CFT) Group for Older Adults
  “COVID-19 restrictions limited recruitment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.